CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $225K invested in Can-Fite BioPharma in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$107K
2
+$13K
3
+$2K

Top Sellers

1
-$101K
2
-$66K
3
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$107K
2
$100K
3
$13K
4
$2K
5
$1.76K
6
$1K
7
–
8
–